← FDA Drug Approvals (Drugs@FDA)

TRIESENCE

NDA · New Drug Application · Sponsor: HARROW EYE · Approved 2007-11-29

Drug application

FDA Application #
NDA022048
Application type
New Drug Application
Brand name
TRIESENCE
Generic name
TRIAMCINOLONE ACETONIDE
Active ingredients
TRIAMCINOLONE ACETONIDE
Dosage form
INJECTABLE
Route
INTRAVITREAL
Marketing status
Prescription
Sponsor
HARROW EYE
Manufacturer
Harrow Eye, LLC
First approval
2007-11-29

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown